We are live on ! Find out more
HVC

Healthcare Value Capital Portfolio holdings

AUM $50.7M
1-Year Est. Return 24.72%
This Fund
S&P 500
This Quarter Est. Return
-8.71%
1 Year Est. Return
+24.72%
3 Year Est. Return
+18.99%
5 Year Est. Return
+98.49%
10 Year Est. Return
–
AUM
$93.3M
AUM Growth
+$30.2M
Cap. Flow
+$8.4M
Cap. Flow %
8.99%
Top 10 Hldgs %
81.82%
Holding
28
New
8
Increased
3
Reduced
2
Closed
7

Top Buys

Rank Stock Value
1
NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
+$7.37M
2
AMGN icon
Amgen
AMGN
+$3.76M
3
GILD icon
Gilead Sciences
GILD
+$3.72M
4
AGN
Allergan plc
AGN
+$3.11M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$2.99M

Top Sells

Rank Stock Value
1
DGX icon
Quest Diagnostics
DGX
+$5.6M
2
QLTI
QLT Inc
QLTI
+$4.44M
3
ANIP icon
ANI Pharmaceuticals
ANIP
+$3.06M
4
CYTK icon
Cytokinetics
CYTK
+$918K
5
TWM icon
ProShares UltraShort Russell2000
TWM
+$721K

Sector Composition

Rank Sector Weight
1 Healthcare 62.46%
2 Miscellaneous 37.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMAG
26
PUT
DELISTED
AMAG Pharmaceuticals
AMAG
– –
-75,000
Closed -$1.84M
KITE
27
PUT
DELISTED
Kite Pharma, Inc.
KITE
– –
-8,600
Closed -$480K
QLTI
28
DELISTED
QLT Inc
QLTI
– –
-2,157,200
Closed -$4.44M
1
2

Similar funds

C
Castlelake Minneapolis, Minnesota $48.5M AUM 87.77% 1-Year Est. Return
CC
Cedar Capital Barrington, Illinois $54.9M AUM 33.3% 1-Year Est. Return
FCOI
FirstMark Capital OF II New York $44.1M AUM 18.15% 1-Year Est. Return
FCOI
FirstMark Capital OF I New York $43.1M AUM 6.31% 1-Year Est. Return
BI
BCBSM Inc Eagan, Minnesota $42.4M AUM 0.4% 1-Year Est. Return
KC
Kelso & Company New York $42.3M AUM
SCIM
Spring Creek Investment Management Philadelphia, Pennsylvania $42.3M AUM 31.86% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

Healthcare Value Capital's Q4 2016 Portfolio in Review

As of Q4 2016, Healthcare Value Capital held 28 positions worth $93.3M, up 48% from $63.1M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Healthcare Value Capital deployed $8.4M of net new capital in Q4 2016, opening 8 new positions and adding to 3 existing holdings. Its largest new stake was Novelion Therapeutics Inc. Common Shares: 831,440 shares worth $7M.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, down from 85% a quarter earlier, followed by Miscellaneous.

On the sell side, the largest reduction was ANI Pharmaceuticals, an estimated $3.06M trimmed.

  • Healthcare Value Capital's largest Q4 2016 buy was Novelion Therapeutics Inc. Common Shares: 831,440 shares worth $7M.
  • Healthcare Value Capital added most to Gilead Sciences in Q4 2016, an estimated $3.72M increase.
  • Healthcare Value Capital's biggest Q4 2016 reduction was ANI Pharmaceuticals, cutting an estimated $3.06M.
  • Healthcare Value Capital fully exited Quest Diagnostics in Q4 2016, selling an estimated $5.6M.
  • Healthcare Value Capital's ten largest holdings make up 82% of its $93.3M portfolio in Q4 2016.
  • Healthcare Value Capital opened 8 new positions and closed 7 in Q4 2016.
  • Healthcare Value Capital's portfolio value rose 48% quarter-over-quarter to $93.3M.

Based on Healthcare Value Capital's 13F filing for Q4 2016, filed 10 Feb 2017.